Hologic Inc: (NASD: HOLX)

$20.75

-0.29 (-1.38%)

Volume 1,265,320

Jun 19 12:50 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		20.60 - 21.10
	
		52wk Low - High
		17.13 - 23.96
	
		Previous Close
		21.04
	
		Avg. Volume
		2,846,546
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		5.67 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.18
	
		P/E (F1)
		13.67
	
		Current Year Est.
		1.54
	
		Quarterly Earnings ESP 
		5.41%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		182 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 06/18/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            13.67
                        
                            PEG Ratio
                            1.15
                        
                            Current Year Est.
                            1.54
                        
                            Current Quarter Estimate
                            0.37
                        
                            Most Accurate Estimate
                            0.39
                        
                            Earnings ESP 
                            5.41%
                        
                            Next Earnings Report Date
                            08-05-2013
                        
                            EPS Last Year
                            1.45
                        
                            Expected Earnings Growth
                            11.86%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests.  The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care.  The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.   
Full HOLX Company Report

 Analyst Report on HOLX

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
HOLX Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (09/2013)	Next Year (09/2014)
Average Estimate	0.37	0.44	1.54	1.76
Number of Estimates	14	13	16	16
Low Estimate	0.36	0.41	1.50	1.62
High Estimate	0.39	0.46	1.57	NA
Year Ago EPS	0.35	0.37	1.38	1.54
EPS Growth	5.31%	19.75%	11.55%	14.58%

More HOLX Estimates

Average Earnings Estimates for HOLX

EPS Growth for HOLX

Industry Analysis

Name	Symbol	Previous Close
HOLOGIC INC	HOLX	21.04
NATUS MEDICAL	BABY	14.42
CRYOLIFE INC	CRY	6.21
DELCATH SYS INC	DCTH	0.45
GLOBUS MEDICAL	GMED	15.72
HEARTWARE INTL	HTWR	94.29
MELA SCIENCES	MELA	0.83
OXYSURE SYSTEMS	OXYS	0.79
SUNSHINE HEART	SSH	6.05
ABIOMED INC	ABMD	22.00

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Quest and Hologic Extend Ties

Jun 07, 2013

The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Index Bullish, CurrencyShares Japanese Yen Trust, CurrencyShares Euro Trust, CurrencyShares British...

May 30, 2013

Good News for HOLX after Weak 2Q13

May 29, 2013

HOLX Beats Earnings, View Slashed

May 07, 2013

Conceptus Beats Earnings, Merger Announced

Apr 30, 2013

More Backing for HOLX Tomosynthesis

Apr 17, 2013

Hologic Reiterated at Neutral

Apr 08, 2013

HOLX to Feature Innovative Products

Mar 25, 2013

More HOLX Zacks Commentary

Financials

EPS TTM	1.45
Sales	2,003
Net Income	-102
Price/Earnings	14.51
Price/Book	1.88
Price/Cash Flow	7.74
Price/Sales	2.46

More HOLX Financials

News

Analysis of Relative Performance in the Health Care Equipment Industry for Shares of Hologic (HOLX, THOR, MDT, BSX, COV) - Financial News Network Online - News Corner

Jun 19, 2013

Shares of Hologic Under Pressure, Down 1.4% - Financial News Network Online - Market Movers

Jun 19, 2013

Quest Diagnostics and Hologic establish strategic alliance - Datamonitor

Jun 18, 2013

Vitro Diagnostics in Canadian Market Forecast to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture - M2

Jun 18, 2013

HOLOGIC DENSITOMETER X-RAY REPAIR - Fedbizopps

Jun 17, 2013

HOLOGIC DENSITOMETER X-RAY REPAIR - Fedbizopps

Jun 17, 2013

Hologic (HOLX) Showing Bullish Technicals With Support At $21.14 - Freshbrewedmedia

Jun 14, 2013

Sirona Dental Systems has Relatively Underperformed its Peers in the Health Care Equipment Industry (SIRO, MR, HOLX, DXCM, NUVA) - Financial News Network Online - News Corner

Jun 14, 2013

See All News Stories on HOLX

Broker Recommendations

Current ABR	1.67
ABR (Last Week)	1.67
# of recs in ABR	20
Average Target Price	24.31
Industry Rank by ABR	182 out of 265
Rank in Industry	9 out of 55

More HOLX Broker Recommendations

Day Low - High	20.60 - 21.10
52wk Low - High	17.13 - 23.96
Previous Close	21.04
Avg. Volume	2,846,546
Industry	MED INSTRUMENTS
Market Cap	5.67 B
Div - Yield	0.00 - 0.00
Beta	1.18
P/E (F1)	13.67
Current Year Est.	1.54
Quarterly Earnings ESP	5.41%

P/E (F1)	13.67
PEG Ratio	1.15
Current Year Est.	1.54
Current Quarter Estimate	0.37
Most Accurate Estimate	0.39
Earnings ESP	5.41%
Next Earnings Report Date	08-05-2013
EPS Last Year	1.45
Expected Earnings Growth	11.86%

Username: Password:

Remember me [?]

Hologic Inc: (NASD: HOLX)

$20.75

-0.29 (-1.38%)

Volume 1,265,320

Jun 19 12:50 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description